EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck

Nupur Nigam, Benjamin Bernard, Samantha Sevilla, Sohyoung Kim, Mohd Saleem Dar, Daniel Tsai, Yvette Robbins, Kyunghee Burkitt, Cem Sievers, Clint T Allen, Richard L Bennett, Theophilus T Tettey und 26 weitere

Cell Reports · 2023-07 · 42 (7) · 112823

DOI: 10.1016/j.celrep.2023.112823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-07. Verfasst von Nupur Nigam und 37 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Histone-Lysine N-Methyltransferase, Interferon Type I, Papillomavirus Infections. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Intramural NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancers often display immune escape, but the mechanisms are incompletely understood. Herein, we identify SMYD3 as a mediator of immune escape in human papilloma virus (HPV)-negative head and neck squamous cell carcinoma (HNSCC), an aggressive disease with poor response to immunotherapy with pembrolizumab. SMYD3 depletion induces upregulation of multiple type I interferon (IFN) response and antigen presentation machinery genes in HNSCC cells. Mechanistically, SMYD3 binds to and regulates the transcription of UHRF1, encoding for a reader of H3K9me3, which binds to H3K9me3-enriched promoters of key immune-related genes, recruits DNMT1, and silences their expression. SMYD3 further maintains the repression of immune-related genes through intragenic deposition of H4K20me3. In vivo, Smyd3 depletion induces influx of CD8+ T cells and increases sensitivity to anti-programmed death 1 (PD-1) therapy. SMYD3 overexpression is associated with decreased CD8 T cell infiltration and poor response to neoadjuvant pembrolizumab. These data support combining SMYD3 depletion strategies with checkpoint blockade to overcome anti-PD-1 resistance in HPV-negative HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsHistone-Lysine N-MethyltransferaseInterferon Type IPapillomavirus InfectionsSquamous Cell Carcinoma of Head and NeckHumansCCAAT-Enhancer-Binding ProteinsCD8-Positive T-LymphocytesUbiquitin-Protein Ligases

Stichwörter der Autor:innen

CP: CancerCP: ImmunologySMYD3antitumor immune responsehead and neck cancerinterferon response

Substanzen

CCAAT-Enhancer-Binding ProteinsHistone-Lysine N-MethyltransferaseInterferon Type ISMYD3 protein, humanUbiquitin-Protein LigasesUHRF1 protein, human

Autor:innen und Institutionen

  • Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD 20892, USA.
  • Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Advanced Biomedical Computational Science, Frederick National Laborat…
  • Laboratory of Receptor Biology and Gene Expression, NCI, NIH, Bethesda, MD 20892, USA.
  • Translational Tumor Immunology Program, NIDCD, NIH, Bethesda, MD 20892, USA.
  • University of Florida Cancer Center, Gainesville, FL 32610, USA.
  • National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.

Förderung

  • NCI NIH HHS
  • Intramural NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • National Institute of Biomedical Innovation

Zitieren

APA

Nigam, N., Bernard, B., Sevilla, S., Kim, S., Dar, M. S., Tsai, D., Robbins, Y., Burkitt, K., Sievers, C., Allen, C. T., Bennett, R. L., Tettey, T. T., Carter, B., Rinaldi, L., Lingen, M. W., Sater, H., Edmondson, E. F., Moshiri, A., Saeed, A., …, & Saloura, V. (2023). SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck. Cell Reports, 42(7), 112823. https://doi.org/10.1016/j.celrep.2023.112823

Vancouver

Nigam N, Bernard B, Sevilla S, Kim S, Dar MS, Tsai D, et al. SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck. Cell Reports. 2023;42(7):112823. doi:10.1016/j.celrep.2023.112823

BibTeX
@article{Nigam2023,
  author = {Nigam, Nupur and Bernard, Benjamin and Sevilla, Samantha and Kim, Sohyoung and Dar, Mohd Saleem and Tsai, Daniel and Robbins, Yvette and Burkitt, Kyunghee and Sievers, Cem and Allen, Clint T and Bennett, Richard L and Tettey, Theophilus T and Carter, Benjamin and Rinaldi, Lorenzo and Lingen, Mark W and Sater, Houssein and Edmondson, Elijah F and Moshiri, Arfa and Saeed, Abbas and Cheng, Hui and Luo, Xiaolin and Brennan, Kevin and Koparde, Vishal and Chen, Chen and Das, Sudipto and Andresson, Thorkell and Abdelmaksoud, Abdalla and Murali, Madhavi and Sakata, Seiji and Takeuchi, Kengo and Chari, Raj and Nakamura, Yusuke and Uppaluri, Ravindra and Sunwoo, John B and Van Waes, Carter and Licht, Jonathan D and Hager, Gordon L and Saloura, Vassiliki},
  title = {SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {7},
  pages = {112823},
  doi = {10.1016/j.celrep.2023.112823}
}
Kostenlos starten →